GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Otsuka Holdings Co Ltd (OTCPK:OTSKY) » Definitions » Investments And Advances

Otsuka Holdings Co (Otsuka Holdings Co) Investments And Advances : $0 Mil (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Otsuka Holdings Co Investments And Advances?

Otsuka Holdings Co's Investments And Advances for the quarter that ended in Mar. 2024 was $0 Mil.


Otsuka Holdings Co Investments And Advances Historical Data

The historical data trend for Otsuka Holdings Co's Investments And Advances can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Otsuka Holdings Co Investments And Advances Chart

Otsuka Holdings Co Annual Data
Trend Mar14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Investments And Advances
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Otsuka Holdings Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Investments And Advances Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Otsuka Holdings Co Investments And Advances Calculation

Investments And Advances includes all the non-current investments in affiliates, real estate, securities, etc.


Otsuka Holdings Co (Otsuka Holdings Co) Business Description

Traded in Other Exchanges
Address
2-9 Kanda-Tsukasamachi, Chiyoda-ku, Tokyo, JPN, 101-0048
Otsuka Holdings Co Ltd is a Japan-based company operates in pharmaceuticals, nutraceuticals and consumer products. Business activity of the company includes providing healthcare solutions in the areas of nervous system, oncology, cardiovascular system, respiratory system, infectious disease and others. It is also engaged in the research and development of functional foods and beverages, such as electrolyte drinks, nutritional foods, soy snacks and dietary food. In addition it also operates multiple businesses related to chemicals, transportation, warehousing, and electronic equipment. Geographically, it operates in Japan, North America and in other regions of which Japan accounts for larger share of revenue.